Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
An accumulation of experimental data suggests that N-methyl-D-aspartate (NMDA) receptor antagonists will prevent ischemic neuronal injury following transient global ischemia and reduce infarct volumes following focal ischemic insults. The excitotoxic hypothesis states that the excitatory amino acid...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
1990
|